Hypercalcemia is a common and life-threatening complication of cancer. In patients with solid tumors, the occurance of hypercalcemia without skeletal metastases suggests that a humoral mediator is responsible. Considerable evidence supports the proposal that this mediator is a tumor product that mimics parathyroid hormone (PTH) by activating the same receptor, although it is a distinct gene product. Such proteins are characteristically present in both conditioned culture medium and extracts of solid tumors causing hypercalcemia. Increases in the level of bioactive PTH in serum and of nephrogenous cyclic AMP and phosphate in the urine of hypercalcemic patients suggest that such PTH-like proteins have humoral effects. We have obtained evidence that after considerable purification, a PTH-like protein from human renal carcinoma cells retains direct bone-resorbing effects. We propose to complete the purification of this protein, determine whether it directly causes hypercalcemia, and develop a radioimmunoassay to detect it in serum and tumor extracts. Together, these results will critically test the hypothesis that a PTH-like protein is the mediator of hypercalcemia secreted by solid tumors. The physiologic role of a PTH-like protein will be clarified by studies of cultured keratinocytes, which have recently been shown to secrete a protein that is indistinguishable from the tumor product. In breast cancer, skeletal metastases characteristically precede the development of hypercalcemia, indicating that accelerated bone resorption has a local cause. We hypothesize that a transforming growth factor (TGF-Alpha) is a local mediator of the skeletal effects of breast carcinoma; others have suggested it also has humoral effects when secreted by other tumors. We will use a panel of specific antagonists to determine whether bone resorption produced by breast or other solid tumor cells is mediated by TGF-Alpha. These studies will provide a basis for the understanding, and ultimately the treatment, of hypercalcemia in malignancy.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA034738-03
Application #
3172528
Study Section
General Medicine B Study Section (GMB)
Project Start
1986-08-15
Project End
1989-07-31
Budget Start
1988-08-01
Budget End
1989-07-31
Support Year
3
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Budayr, A A; Zysset, E; Jenzer, A et al. (1994) Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein. J Bone Miner Res 9:521-6
Schermer, D T; Bradley, M S; Bambino, T H et al. (1994) Functional properties of a synthetic chicken parathyroid hormone-related protein 1-36 fragment. J Bone Miner Res 9:1041-6
Marino, M T; Asp, A A; Budayer, A A et al. (1993) Hypercalcaemia and elevated levels of parathyroid hormone-related protein in cutaneous squamous/basal cell carcinoma. J Intern Med 233:205-7
Strewler, G J; Budayr, A A; Clark, O H et al. (1993) Production of parathyroid hormone by a malignant nonparathyroid tumor in a hypercalcemic patient. J Clin Endocrinol Metab 76:1373-5
Strewler, G J; Chan, S D; Globus, R K et al. (1992) Actions of parathyroid hormone-related protein as an embryonic differentiation factor. J Endocrinol Invest 15:57-62
Schermer, D T; Chan, S D; Bruce, R et al. (1991) Chicken parathyroid hormone-related protein and its expression during embryologic development. J Bone Miner Res 6:149-55
Klein, R F; Nissenson, R A; Strewler, G J (1991) Pertussis toxin inhibits hormonal stimulation of bone resorption in fetal rat limb bones. J Pharmacol Exp Ther 258:877-81
Cohen, F E; Strewler, G J; Bradley, M S et al. (1991) Analogues of parathyroid hormone modified at positions 3 and 6. Effects on receptor binding and activation of adenylyl cyclase in kidney and bone. J Biol Chem 266:1997-2004
Chan, S D; Strewler, G J; King, K L et al. (1990) Expression of a parathyroid hormone-like protein and its receptor during differentiation of embryonal carcinoma cells. Mol Endocrinol 4:638-46
Chan, S D; Strewler, G J; Nissenson, R A (1990) Transcriptional activation of Gs alpha expression by retinoic acid and parathyroid hormone-related protein in F9 teratocarcinoma cells. J Biol Chem 265:20081-4

Showing the most recent 10 out of 16 publications